Medifast (MED) Profit After Tax (2010 - 2026)

Medifast has reported Profit After Tax for 17 years, with the latest figure at -$2.1 million in Q1 2026.

• For the quarter ending Q1 2026, Profit After Tax fell 174.87% year-over-year to -$2.1 million; the trailing twelve-month figure through Mar 2026 stood at -$20.0 million (down 186.19% YoY), and the FY2025 full-year result was -$18.7 million, down 992.97% from the prior year.
• Profit After Tax for Q1 2026 stood at -$2.1 million, up from -$18.1 million in the prior quarter.
• The five-year high for Profit After Tax was $41.8 million in Q1 2022, with the low at -$18.1 million in Q4 2025.
• Historically, Profit After Tax has averaged $13.2 million across 5 years, with a median of $6.0 million in 2023.
• The largest YoY upside for Profit After Tax was 130.41% in 2025 against a maximum downside of 2362.05% in 2025.
• Medifast's Profit After Tax stood at $26.5 million in 2022, then tumbled by 77.24% to $6.0 million in 2023, then tumbled by 86.73% to $801000.0 in 2024, then slumped by 2362.05% to -$18.1 million in 2025, then soared by 88.29% to -$2.1 million in 2026.
• The last three Profit After Tax figures came in at -$2.1 million (Q1 2026), -$18.1 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.